Stratos Wealth Partners’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,550
Closed -$293K 2785
2018
Q3
$293K Hold
11,550
0.01% 715
2018
Q2
$291K Buy
11,550
+1,550
+16% +$38.3K 0.01% 758
2018
Q1
$246K Buy
+10,000
New +$257K 0.01% 819

Other funds holding LDRS

Stratos Wealth Partners's LDRS Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q4 2018, closing a stake of 11,550 shares — an estimated $293K sold.

Stratos Wealth Partners first reported a position in LDRS in Q1 2018 and held it in 3 quarters. The position peaked at $293K in Q3 2018. 13 funds tracked by Wall St. Rank hold LDRS as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Innovator IBD ETF Leaders ETF position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 11,550 Innovator IBD ETF Leaders ETF shares in Q4 2018, an estimated $293K.
  • Stratos Wealth Partners first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 3 quarters.
  • Stratos Wealth Partners's Innovator IBD ETF Leaders ETF position peaked at $293K in Q3 2018.
  • 13 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.